Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire

Journal of Infectious Diseases

Volumn 192, Issue 12, 2005, Pages 2124-2128

  Hennessey, Karen A ^a,f   Lago, Hugues ^d   Diomande, Fabien ^d   Akoua Koffi, Chantal ^c   Caceres, Victor M ^a   Pallansch, Mark A ^b   Kew, Olen M ^b   Nolan, Monica ^d   Zuber, Patrick L F ^e  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c INSTITUT PASTEUR DE CÔTE D'IVOIRE   (Côte d’Ivoire)

^d Projet Retrovirus Cote d'Ivoire   (Côte d’Ivoire)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; POLIOMYELITIS VACCINE;

ADULT; AGED; ARTICLE; COTE D'IVOIRE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; SEROLOGY; VIRUS SHEDDING;

ADOLESCENT; ADULT; AGED; COTE D'IVOIRE; FECES; FEMALE; HIV INFECTIONS; HUMANS; IMMUNIZATION PROGRAMS; MALE; MIDDLE AGED; POLIOVIRUS; POLIOVIRUS VACCINES; VIRUS SHEDDING;

EID: 27144461892     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/498166     Document Type: Article

References (27)

1. World Health Assembly. Global eradication of poliomyelitis by the year 2000 [WHA resolution no. WHA41.28]. Geneva: World Health Organization, 1988.
2. Centers for Disease Control and Prevention. Progress toward global eradication of poliomyelitis, January 2003-April 2004. MMWR Morb Mortal Wkly Rep 2004; 53:532-5.
3. Centers for Disease Control and Prevention. Laboratory surveillance for wild poliovirus and vaccine-derived poliovirus, 2000-2001. MMWR Morb Mortal Wkly Rep 2002; 51:369-71.
4. Centers for Disease Control and Prevention. Outbreak of poliomyelitis-Dominican Republic and Haiti, 2000. MMWR Morb Mortal Wkly Rep 2000; 49:1094, 1103.
5. Centers for Disease Control and Prevention. Acute flaccid paralysis associated with circulating vaccine-derived poliovirus-Philippines, 2001. MMWR Morb Mortal Wkly Rep 2001; 50:874-5.
6. Centers for Disease Control and Prevention. Circulation of a type 2 vaccine-derived poliovirus-Egypt, 1982-1993. MMWR Morb Mortal Wkly Rep 2001; 50:41-42, 51.
7. Kew O, Morris-Glasgow V, Landaverde M, et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 2002; 296:356-9.
8. Kew O, Wright P, Agol V, et al. Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ 2004; 82:16-23.
9. Bellmunt A, May G, Zell R, Pring-Akerblom P, Verhagen W, Heim A. Evolution of poliovirus type 1 during a 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology 1999; 265:178-84.
10. Davis L, Bodian D, Price D, Butler I, Vickers J. Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. N Engl J Med 1977; 297:241-5.
11. Hara M, Saito Y, Komatsu Y. Antigenic analysis of poliovirus isolated from a child with agamaglobulimeia and paralytic poliomyelitis after Sabin vaccine administration. Microbiol Immunol 1981; 25:905-13.
12. Misbah S, Lawrence P, Kurtz J, Chapel H. Prolonged faecal excretion of poliovirus in a nurse with common variable hypogammaglobulinaemia. Postgrad Med J 1991; 67:301-3.
13. Lopez C, Biggar W, Park B, Good R. Nonparalytic poliovirus infections in patients with severe combined immunodeficiency diseases. J Pediatr 1974; 84:497-502.
14. Martin J, Dunn G, Hull R, Paterl V, Minor P. Evolution of the strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol 2000; 74:3001-10.
15. MacLennan C, Dunn G, Huissoon A, et al. Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet 2004; 363:1509-13.
16. Halsey N, Pinto J, Espinosa-Rosales F, et al. Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom. Bull World Health Organ 2004; 82:3-8.
17. Khetsuriani N, Prevots D, Quick L, et al. Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis. J Infect Dis 2003; 188:1845-52.
18. Fiore L, Plebani A, Buttinelli G, Fiore S, Donati V, et al. Search for poliovirus long-term excretors among patients affected by agammaglobulinemia. Clin Immunol 2004; 111:98-102.
19. Odoom M, Tuite G, Dunn G, et al. Long-term excretion of vaccine-derived poliovirus by a healthy child. J Virol 2004; 78:13839-47.
20. Sutter RW, Prevots DR. Vaccine-associated paralytic poliomyelitis among immunodeficient persons. Infect Med 1994; 11:426, 429-30, 435-8.
21. Chitsike I, van Furth R. Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe: case report. BMJ 1999; 318:841-3.
22. Mas Lago P, Caceres V, Galindo M, et al. Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio-vaccination after global eradication. Int J Epidemiol 2001; 30:1029-34.
23. Benyesh-Melnick M, Melnick JL, Rawls WE, et al. Studies on the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter. Am J Epidemiol 1967; 86:112-36.
24. World Health Organization, Expanded Programme on Immunization. Manual for the virological investigation of poliomyelitis. Geneva: WHO, 1997.
25. Dean AG, Dean JA, Coulombier D, et al. Epi Info, version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Atlanta: Centers for Disease Control and Prevention, 1995.
26. Onorato IM, Markowitz LE. Immunizations, vaccine-preventable diseases, and HIV infection. In: Wormser G, ed. AIDS and other manifestations of HIV infection. 2nd ed. New York: Raven Press, 1992:671-81.
27. Sutter RW, Caceres VM, Mas Lago P. The role of routine polio immunization in the post-certification era. Bull World Health Organ 2004; 82:31-9.